Kavian, Niloufar <br/><br/>
Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model.  [electronic resource] 

 -  Arthritis and rheumatism  Nov 2010 
 - 3477-87 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1529-0131 
<br/><br/><label>Standard No.: </label>10.1002/art.27626  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADAM Proteins--metabolism<br/>ADAM17 Protein<br/>Adult<br/>Analysis of Variance<br/>Animals<br/>Blotting, Western<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Fluorescent Antibody Technique<br/>Humans<br/>Mice<br/>Receptors, Notch--metabolism<br/>Scleroderma, Systemic--chemically induced<br/>Signal Transduction<br/>Skin--metabolism<br/>Statistics, Nonparametric